HUM Humana Inc. Loading...

From GL earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
11:00
Feb 05 ◎
Matt Darden Co-Chief Executive Officer, Globe Life Inc. GL Q4 FY25 call
A major shift in the Medicare market is underway: beneficiaries are moving from Medicare Advantage plans to Medicare Supplement plans due to MA reimbursement cuts and provider network constraints, fueling Globe Life's 50% sales surge at United American in 2025. — This structural shift pressures MA carriers (UNH, HUM, CVS) on enrollment and margins, while benefiting Med Supp writers like Globe Life.
HUM
MED

About HUM Analyst Coverage

Buzzberg tracks HUM (Humana Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Matt Darden.